Concussion is one of the most common, and most mismanaged, injuries in sport. For athletes in contact and combat disciplines, the pressure to return quickly is real, and the consequences of returning too early are well-documented.
A growing body of research has shifted the management of concussion from extended rest toward structured, progressive return-to-sport protocols guided by symptom monitoring and objective assessment.
The widely adopted framework for concussion recovery is a six-step return-to-play (RTP) progression, endorsed by organisations including Sport New Zealand and the CDC:
Two large systematic reviews define what typical recovery looks like. A BJSM meta-analysis of 278 studies (covering data to March 2022) found mean symptom-free time of 14.0 days (95% CI: 12.7–15.4), with return to sport occurring at a mean of 19.8 days (95% CI: 18.8–20.7).
A separate review of 65 studies covering 21,966 patients found 80% of athletes return to sport within 21 days, with symptom resolution occurring between 2–11 days across that cohort. [14]
These figures represent population averages. Research consistently shows that 20–30% of athletes experience prolonged symptoms extending beyond four weeks, and recovery patterns vary significantly based on pre-existing conditions, injury severity, and how quickly a structured protocol is initiated. [1]
Early intervention is now a consensus recommendation. The 6th International Conference on Concussion in Sport advises 24–48 hours of relative rest, followed by progressive light aerobic exercise, replacing the older total-rest model.
Multidisciplinary care incorporating vestibular therapy has been shown to accelerate recovery, particularly in paediatric athletes. Modern active recovery protocols have reduced median recovery times from 11–28 days to as few as 5–7 days. [2][16]
One factor that consistently extends timelines and is entirely preventable: continuing to play after injury. Athletes who remain in play following a concussive event show significantly longer recovery periods. Early removal from training or competition and prompt clinical evaluation are identified across multiple reviews as critical determinants of outcome. [15]
Combat sports sit in a separate category from non-contact and team sports. The biomechanics of striking disciplines (repeated sub-concussive impacts, knockout risk, and head trauma as a core competitive mechanism) demand tighter regulatory controls and longer mandatory stand-down periods.
– Memory disruption
Symptom count and severity act in a dose-dependent manner: more symptoms and greater severity combine additively to extend recovery (P=0.020 and P=0.023 respectively). [3]
In combat sport athletes with significant fight exposure, neurological recovery is complicated by pre-existing structural changes that are invisible on standard assessment.
Meta-analyses identify cavum septum pellucidum (CSP) in 23.30% of boxers and brain atrophy in 30.41%, both markers of cumulative trauma that compromise baseline neurological function before any single concussion is sustained. [10]
Genetic factors compound this. Athletes carrying the APOE ε4 allele who have competed in more than 12 bouts face substantially elevated risk of severe cognitive impairment, suggesting that genetic predisposition interacts with exposure volume in ways current RTP protocols do not yet account for. [3]
Female athletes show higher rates of slow recovery (41% versus 36%, P=0.05) and higher baseline concussion risk (OR=1.71). This pattern holds across multiple large reviews; female sex is a consistent trend in extended recovery timelines, though confidence intervals overlap, suggesting the effect is real but variable across populations.
Practice injuries, as opposed to competition injuries, are also associated with delayed return (71% vs. 65%, P=0.04). [7][14].
Younger athletes and non-elite sport participants show worse prognosis compared to elite-level counterparts, with paediatric reviews noting significant protocol variability by age, sex, and sport.
Standardised symptom-based RTP (rather than time-based protocols) is recommended across all age groups, with particular attention to paediatric populations where females frequently require extended timelines. [16]
Sleep disturbance is one of the most prevalent and under-addressed factors in concussion recovery. A retrospective cohort study of 417 patients found that 34% reported clinically significant sleep disturbance following concussion, with the rate higher in non-sport concussions (45%) than sport-related concussions (29%, P=0.01). [18]
The clinical significance is substantial. Sleep disturbance was associated with a 3- to 4-fold increase in recovery time in the same cohort, making it one of the most impactful modifiable factors in concussion management. [18]
Mechanistically, sleep is the period during which the glymphatic system clears metabolic waste from the brain, including the proteins that accumulate following neurological injury. Disruption to this process is thought to impair cellular repair and prolong the inflammatory cascade that underlies post-concussion symptoms. [19]
Melatonin showed clinical utility in the same retrospective analysis: it improved sleep disturbance in 67% of treated patients, and the treated group showed faster overall recovery trajectories. [18]
However, high-quality randomised controlled trial evidence for pharmacological sleep interventions in concussion remains limited, and current guidance primarily emphasises sleep hygiene and environmental modification as first-line strategies. [19, 21]
Current consensus guidance recommends evaluating sleep quality as part of standard concussion assessment, alongside symptom scoring, vestibular testing, and cognitive evaluation. Athletes who report poor or disrupted sleep should have this factored into their individual recovery timeline.
In cases of persistent sleep disturbance that does not respond to hygiene interventions, referral to sleep medicine may be appropriate. Sleep evaluation should be treated as a standing component of concussion management, not a secondary concern addressed only when athletes report it independently. [21]
Research consistently shows that in sex-comparable sports, female athletes sustain concussion at higher rates than their male counterparts. A 2009 BJSM review identified higher incidence in female athletes across comparable sports, and a 2023 scoping review corroborated this pattern across a range of disciplines. [22, 20]
Female athletes also report more somatic symptoms following concussion, particularly headache and sleep disturbance. A 2020 systematic review found that female athletes were more susceptible to concussion, more symptomatic following injury, and showed evidence of more prolonged recovery in some cohorts. [23] Some large-scale analyses report an odds ratio of 1.71 for extended recovery in female athletes, though findings across all populations are not fully consistent and confidence intervals reflect significant variability between study designs. [7]
Proposed mechanisms include biomechanical differences in neck musculature that reduce the ability to attenuate rotational acceleration forces, hormonal influences on neurological vulnerability at different points in the menstrual cycle, and differences in how symptoms are recognised and reported. No single explanation is established, and available evidence suggests the relationship between biological sex and concussion outcomes is multifactorial. [24]
Youth athletes present a distinct clinical picture from adult populations. Paediatric concussion research consistently shows slower and more variable recovery trajectories, greater susceptibility to the cognitive effects of injury, and heightened sensitivity to inappropriate management. [16]
Extended complete rest is not recommended for youth athletes. Evidence from paediatric cohorts indicates that prolonged cognitive restriction can worsen outcomes by increasing social isolation, heightening anxiety, and compounding the academic stress created by time away from school. [25]
Current international guidelines, including the Australian Youth Concussion Guidelines (2024) and the CDC Heads Up framework, align on a graduated approach that prioritises return-to-learn before return-to-sport. [26, 27]
The return-to-learn sequence proceeds as follows: relative rest for 24–48 hours; symptom-limited cognitive activity at home; partial school attendance with accommodations; full attendance with accommodations; full academic load without accommodations. School accommodations during recovery include reduced homework volume, shortened school days, regular rest breaks, quiet testing environments, and delayed assessments where needed. [25]
Return to contact sport should not occur until the athlete is tolerating full school attendance without symptom exacerbation. This sequencing ensures cognitive and neurological demands are managed before physical demands are reintroduced, a principle supported by paediatric concussion guidelines across New Zealand, Australia, and the United States. [26, 27]
The evidence base for early active recovery in concussion management has grown substantially over the past decade. Light aerobic activity, initiated within 48 hours of injury, is now standard care under all major international concussion guidelines. The previous rest-only model has been superseded by a protocol-based approach in which symptom-limited exercise is the active intervention, not the absence of intervention. [28]
The most studied protocol is sub-symptom threshold aerobic exercise: exercise performed at approximately 80% of the heart rate at which symptoms are provoked, for 20 minutes, five to six days per week. The threshold is determined by a supervised graded exercise test (typically a Balke treadmill test or stationary bike protocol) and adjusted individually based on the athlete’s response across sessions. [29]
A 2020 systematic review of 12 studies found that sub-symptom aerobic exercise was associated with meaningful symptom improvement in athletes experiencing persistent post-concussion symptoms, supporting its use across the recovery continuum and not only in the acute phase. [29]
A 2019 RCT found that early individualised sub-threshold aerobic exercise initiated within one week of injury produced significantly faster recovery than usual care (standardised rest advice). [30]
A 2025 study found that sub-symptom exercise protocols were also associated with improvements in executive function, a domain frequently impaired following concussion and often the last to resolve. [31]
A practical pacing heuristic used in clinical settings is the “+3 rule”: stopping or reducing activity when symptoms increase by more than 3 points on a 10-point scale. This rule is a useful day-to-day guide for athletes managing activity outside supervised settings.
The underlying evidence base is stronger for the individualised symptom-threshold concept than for any specific fixed numeric cutoff, and clinical protocols should be calibrated to the individual rather than applied as rigid rules. [29]
Blood-based biomarkers represent an active and developing area of concussion diagnostics. While current clinical practice relies on symptom assessment, standardised tools such as the SCAT, and imaging where clinically indicated, research into biochemical markers of neurological injury has produced results with practical clinical application.
The FDA-cleared Banyan Brain Trauma Indicator uses two biomarkers, glial fibrillary acidic protein (GFAP) and ubiquitin C-terminal hydrolase-L1 (UCH-L1), as adjuncts in the evaluation of mild TBI to assist in determining the need for head CT. The assay demonstrated sensitivity of 97.6% and a negative predictive value (NPV) of 99.6% for detecting the absence of intracranial lesions visible on CT, indicating strong utility as a rule-out tool in the acute setting. [32]
GFAP has the largest body of supporting literature. A 2021 meta-analysis of 38 studies found GFAP sensitivity of 71% and specificity of 71% at an optimal diagnostic threshold of 626 pg/mL for CT-visible abnormalities. At a lower threshold of 22 pg/mL, sensitivity increased to 93%, at the cost of reduced specificity. [33]
In sport concussion cohorts specifically, UCH-L1 and S100 beta have also been studied; a 2017 cohort study found UCH-L1 AUC of 0.74 and S100 beta AUC of 0.72 at 6 hours post-injury, with both markers showing moderate diagnostic value in the sport context. [34]
These biomarkers are adjuncts to clinical evaluation, not standalone concussion diagnostic tools. They do not replace symptom monitoring, SCAT assessment, or graduated return-to-sport protocols. Their primary value in current clinical use is in ruling out CT-visible intracranial injury in the acute setting, reducing unnecessary CT exposure while supporting safe triage decisions.
Ongoing research continues to explore their potential in tracking recovery trajectory and predicting prolonged symptoms, but clinical implementation beyond the acute CT-triage role remains under investigation.
Physical symptom resolution is not the only requirement for safe return to sport. Psychological readiness, encompassing the athlete’s confidence to return, their fear of reinjury, and their mental health status, is increasingly recognised as a distinct component of concussion recovery. For many athletes, sitting out is the hardest part of the whole process.
Anxiety and depression are associated with worse concussion prognosis and are risk factors for prolonged RTP. The relationship is bidirectional: pre-existing mood disorders complicate recovery, and the experience of concussion can itself generate or worsen psychological distress, particularly in athletes for whom sport is a primary source of identity and purpose.
In combat sports, coach pressure has been identified as a structural barrier to safe return, with New Zealand guidelines advocating for clinician-led timelines rather than coach or athlete-driven decisions. [3]
Fear of reinjury in combat sports carries additional weight compared to non-contact disciplines. Unlike a hamstring strain, a concussion sustained in sparring or competition creates a direct association between the competitive environment and the mechanism of injury. Athletes returning without adequate psychological preparation may rush contact to prove fitness to themselves, or alternatively avoid full engagement with training. Neither response supports safe return, and both carry secondary injury risk.
The standard six-step protocol does not include a formal psychological readiness assessment, but emerging frameworks advocate for inclusion of validated tools such as the Injury-Psychological Readiness to Return to Sport (I-PRRS) scale as part of the clearance process.
Clinicians working with combat sports athletes should treat psychological readiness as a clearance criterion alongside the standard clinical markers, not as an optional supplementary consideration.
The evidence points to several practical implications for athletes and the coaches who work with them.
The minimum stand-down periods defined in regulatory frameworks are floors, not targets. Athletes with high initial symptom load, prior concussion history, or vestibular impairment will typically require longer than the minimum 37 days.
Treating the minimum as the goal inverts the logic of evidence-based recovery and increases the likelihood of return before full neurological resolution. [3]
Symptom monitoring must be objective, not self-reported under competitive pressure. Athletes in team or combat sport environments are motivated to underreport symptoms. Structured assessment tools including the SCAT, vestibular screening, and neurocognitive testing provide an objective counterweight to the athlete’s stated readiness. An athlete reporting no symptoms three hours before competition is not an appropriate assessor of their own neurological status. [2]
Active recovery should begin early, under clinical supervision. The outdated rest-only model delays recovery. Light aerobic activity within 48 hours, progressed according to symptom response, is now standard care. Athletes with access to structured coaching during this phase are better placed to follow the protocol correctly and maintain engagement without overstepping their symptom threshold. [29, 30]
Sleep quality must be assessed and, where impaired, addressed as a priority within the recovery plan. Sleep disturbance tripling or quadrupling recovery time is not a secondary finding. Athletes and coaches who treat sleep as peripheral to training load management during concussion recovery are working against the evidence. [18]
Return to sport after concussion is no longer a matter of waiting until symptoms resolve. It is a structured, evidence-based process with clear protocols, objective assessment criteria, and meaningful consequences for non-compliance, particularly in combat sports where re-exposure to head trauma is inherent to the activity.
The trend across all sport disciplines is toward earlier active intervention, individualised recovery timelines, and multidisciplinary oversight. For combat sport athletes specifically, regulatory frameworks impose minimum stand-down periods precisely because the cost of premature return is highest in this population.
Emerging evidence on sleep, sex differences, paediatric considerations, and blood-based biomarkers is adding depth to a field previously dominated by time-based and symptom-based protocols alone.
Several limitations apply to the research summarised in this paper. The evidence base for sub-symptom threshold exercise, while promising, relies on a relatively small number of RCTs, and optimal protocol parameters (frequency, intensity, duration) are not yet standardised across guidelines.
Sex difference findings are complicated by methodological heterogeneity and reporting bias, and causal mechanisms remain contested. Biomarker research, while producing strong sensitivity data in the acute CT-triage setting, has not established clear clinical utility for monitoring ongoing recovery or predicting prolonged symptoms.
Paediatric concussion research is an evolving field, and some guidelines have moved ahead of the RCT evidence base they reference. Where findings in this paper are presented as emerging or contested, readers should apply appropriate caution when translating them into individual clinical decisions.
